Mar 5, 2024 11:54PM
Mar 5, 2024 11:53PM
Mar 4, 2024 04:18PM
Mar 4, 2024 04:17PM
Feb 2, 2024 07:00AM
Nov 2, 2023 05:00PM
Nov 2, 2023 07:30AM BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update
Oct 9, 2023 07:30AM
Jul 26, 2023 04:07PM
May 4, 2023 04:58PM
Mar 21, 2023 07:30AM
Mar 8, 2023 07:01AM
Mar 8, 2023 07:00AM
Mar 8, 2023 07:00AM BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
Mar 6, 2023 04:06PM
Mar 6, 2023 04:06PM
Mar 6, 2023 04:05PM
Mar 6, 2023 04:05PM
Mar 8, 2022 07:30AM
May 28, 2021 02:33PM
Feb 12, 2021 08:04AM BridgeBio Pharma Inc. (BBIO) Announces Pricing of 3M Share Secondary Offering of Common Stock at $62.50/sh
Feb 12, 2021 08:00AM
Feb 12, 2021 08:00AM
Feb 11, 2021 04:12PM
Feb 11, 2021 04:10PM
Feb 11, 2021 04:09PM
Feb 11, 2021 04:09PM
Nov 13, 2020 07:35AM BridgeBio Pharma Inc. (BBIO) and Affiliate Navire Pharma Inc. Report First Patient Dosing in Phase 1 Clinical Trial of SHP2 inhibitor BBP-398
May 6, 2020 08:22PM
May 5, 2020 04:06PM
Jun 27, 2019 06:27PM

68,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All